BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
66.09
+0.08 (0.12%)
Nov 5, 2024, 1:19 PM EST - Market open

BioMarin Pharmaceutical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
675.45755.13724.53587.28649.16437.45
Upgrade
Short-Term Investments
255318.68567.01426.6416.23316.36
Upgrade
Cash & Short-Term Investments
930.441,0741,2921,0141,065753.81
Upgrade
Cash Growth
-17.36%-16.86%27.39%-4.83%41.33%-30.48%
Upgrade
Accounts Receivable
777.55633.7461.32373.4448.35377.4
Upgrade
Receivables
777.55633.7461.32373.4448.35377.4
Upgrade
Inventory
1,1791,107894.08776.67698.55680.28
Upgrade
Other Current Assets
169.26141.39104.52110.44129.93130.66
Upgrade
Total Current Assets
3,0572,9562,7512,2742,3421,942
Upgrade
Property, Plant & Equipment
1,0451,1121,1141,0821,0901,070
Upgrade
Long-Term Investments
568.79622.44370.34524.29295.97418.18
Upgrade
Goodwill
196.2196.2196.2196.2196.2197.04
Upgrade
Other Intangible Assets
260.92325.3338.57388.65417.27456.58
Upgrade
Long-Term Deferred Tax Assets
1,5311,5461,5051,4501,432549.42
Upgrade
Other Long-Term Assets
192.5183.5698.7889.274.6356.38
Upgrade
Total Assets
6,8516,8426,3756,0055,8484,690
Upgrade
Accounts Payable
312.32315.51231.24199.68191.43240.98
Upgrade
Accrued Expenses
349.5311.55293.53267.65257.27288.82
Upgrade
Current Portion of Long-Term Debt
-493.88---361.88
Upgrade
Current Portion of Leases
8.068.7810.3810.4611.7510.7
Upgrade
Current Income Taxes Payable
21.042.6516.211.219.663.2
Upgrade
Current Unearned Revenue
2.354.620.716.960.1513.04
Upgrade
Other Current Liabilities
22.440.0436.8160.5422.2913.89
Upgrade
Total Current Liabilities
715.661,177588.88546.5492.55932.5
Upgrade
Long-Term Debt
594.63593.11,0831,0791,075486.24
Upgrade
Long-Term Leases
-38.1226.5133.8444.4950.8
Upgrade
Other Long-Term Liabilities
127.5181.8173.579.69129.8498.12
Upgrade
Total Liabilities
1,4381,8901,7721,7391,7421,568
Upgrade
Common Stock
0.190.190.190.180.180.18
Upgrade
Additional Paid-In Capital
5,7405,6125,4055,1924,9934,833
Upgrade
Retained Earnings
-319.64-621.55-789.2-930.76-861.61-1,721
Upgrade
Comprehensive Income & Other
-7.07-38.65-12.734.74-25.9810.2
Upgrade
Shareholders' Equity
5,4134,9524,6034,2664,1063,122
Upgrade
Total Liabilities & Equity
6,8516,8426,3756,0055,8484,690
Upgrade
Total Debt
602.691,1341,1201,1231,131909.62
Upgrade
Net Cash (Debt)
327.76-60.07171.63-109.51-66-155.81
Upgrade
Net Cash Growth
973.31%-----
Upgrade
Net Cash Per Share
1.70-0.310.91-0.60-0.34-0.87
Upgrade
Filing Date Shares Outstanding
190.58188.68186.53184.03181.83179.93
Upgrade
Total Common Shares Outstanding
190.55188.6186.25183.91181.74179.84
Upgrade
Working Capital
2,3411,7792,1631,7281,8501,010
Upgrade
Book Value Per Share
28.4126.2524.7123.1922.5917.36
Upgrade
Tangible Book Value
4,9564,4304,0683,6813,4932,469
Upgrade
Tangible Book Value Per Share
26.0123.4921.8420.0119.2213.73
Upgrade
Land
-90.7890.7990.4290.4290.42
Upgrade
Buildings
-860.81819.1774.92761.56725.91
Upgrade
Machinery
-796.61736.25688.54644.4573.07
Upgrade
Construction In Progress
-100.01143.38136.74109.14111.9
Upgrade
Leasehold Improvements
-58.2359.5355.2855.1351.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.